Ann Belien, CEO at Rejuvenate Biomed, explores the need for more treatment options for age-related diseases and the opportunities drug repurposing offers these conditions. As the average global lifespan continues to rise, the prevalence of age-related diseases has become an increasing concern. Consequently, treatment options for those diseases are more needed than ever before.  Ageing […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!